BioLife Sciences Inc.

Equities

BLFE

US09076L1035

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 10:17:38 2024-05-01 am EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-99.33%

2023	BioLife Sciences, Inc. Announces the Release of the Prototype of the Its Copper-Infused Microfiber Towels for Second Quarter of the Fiscal Year	CI
2023	Biolife Sciences Inc. Announce Its Copper-Infused Wall Planters to Be Incorporated into Initial Copper Pot Product Line	CI

BioLife Sciences Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022

May 31, 2022 at 07:36 am EDT

BioLife Sciences Inc. reported earnings results for the first quarter ended February 28, 2022. For the first quarter, the company reported net loss was USD 0.132047 million compared to USD 0.067359 million a year ago.

Latest news about BioLife Sciences Inc.

BioLife Sciences, Inc. Announces the Release of the Prototype of the Its Copper-Infused Microfiber Towels for Second Quarter of the Fiscal Year	23-02-23	CI
Biolife Sciences Inc. Announce Its Copper-Infused Wall Planters to Be Incorporated into Initial Copper Pot Product Line	23-02-08	CI
BioLife Sciences Inc. Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm	23-02-02	CI
Biolife Sciences Inc. Announces Slated Release of Its Copper-Infused Fabric Pot Prototype	22-11-22	CI
BioLife Sciences Inc. Expands Product Offerings in the Orthomolecular Medicine and Natural Health Markets with a Focus on Hemp Products	22-08-24	CI
Biolife Sciences Inc. Announces Launch of Hemp-Based Product Line	22-08-17	CI
BioLife Sciences Inc. Announces the Launch of BioLife Copper-Infused Microfiber Towels	22-07-25	CI
BioLife Sciences Inc. announced that it expects to receive $20 million in funding	22-05-31	CI
BioLife Sciences Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022	22-05-31	CI
Biolife Sciences Inc. Introduces Copper Infused Gardening Gloves to Its Newly Formed Horticultural and Agriculture Department	22-03-25	CI
Biolife Sciences Inc. Announces Expansion of Its Newly Formed Orthomolecular Medicine and Natural Health Products Department with Subsector Dedicated to Cannabidiol Sales and Products	22-03-01	CI
BioLife Sciences Inc. Announces the Launch of Their New Antimicrobial Copper-Infused Fabric Pot	22-02-16	CI
BioLife Sciences Inc. Launches a New Life Sciences Division	22-02-08	CI
BioLife Sciences Inc. entered into an agreement to acquire Healthbox, LLC for $ 0.87 million.	22-01-24	CI
BioLife Sciences Inc. Announces the Launch of New Copper Infused Face Masks	21-02-26	CI
Health Canada Testing Confirms Bio Life Hand Sanitizer by Bio Life Sciences Corp./10932540 Canada Inc. Contains Methanol, Which May Cause Serious Health Issues, Especially If Ingested	21-01-29	CI
BioLife Sciences Inc. Announces New Board of Directors	20-12-03	CI
BioLife Sciences Inc. announced that it expects to receive $4.5 million in funding from BeMotion Inc.	20-11-04	CI
Biolife Sciences Announces Agreement to Provide Aircraft Cleaning and Disinfecting Services for the Transportation & Travel Sector	20-11-02	CI
BioLife Sciences Announces the Availability of the FebriDx Ultra-Rapid, Health Canada Approved, Covid-19 Point of Care Test	20-10-26	CI
BioLife Sciences Inc. Announces the Launch of New Antimicrobial Air Filter Technology	20-10-15	CI
Biolife Sciences Inc. Offers Non-Contact Human Temperature Screening Technology	20-10-05	CI
BioLife Sciences Inc. Offers Intelligent, Touchless Vending Machines and Marketplaces	20-09-29	CI
BioLife Sciences Inc. Announces Distribution Agreement With BeMotion Inc	20-09-21	CI
Biolife Sciences Corp. entered into a binding agreement to acquire Rhino Novi, Inc. in a reverse merger transaction for CAD 37.5 million.	20-08-31	CI

Chart BioLife Sciences Inc.

Duration

Period

More charts

Company Profile

BioLife Sciences Inc. is a commercialization accelerator, licensor, and disruptive technologies for the healthcare, beauty, and food and beverage industry sectors. The Companyâs core business develops, licenses and distributes antimicrobial products and disruptive technology. Its solutions include Antimicrobial Copper Air Filters, Copper-Infused Textiles and Copper Infused Fabric Pots. The Company's BioLife antimicrobial copper fabric filter acts as a layer of protection by trapping in bacteria and releasing clean air. BioLife Antimicrobial Copper-Infused Textiles kill viruses and bacteria on contact through preventative clothing and textiles designed to inhibit virus and bacteria reproduction and cross contamination before it starts. Its BioLife Copper Infused Fabric Pots provides plants a healthier home. The copper infusion allows the plants that grow in the pots with additional protections from harmful microbes which can harm plants.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BIOLIFE SCIENCES INC.	-99.33%	4.83K
THERMO FISHER SCIENTIFIC	+8.33%	217B
DANAHER CORPORATION	+6.72%	183B
INTUITIVE SURGICAL, INC.	+10.18%	131B
BOSTON SCIENTIFIC CORPORATION	+24.91%	106B
SIEMENS HEALTHINEERS AG	-0.95%	62.16B
EDWARDS LIFESCIENCES CORPORATION	+10.56%	51.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.89B
AGILENT TECHNOLOGIES, INC.	-0.24%	40.16B
GE HEALTHCARE TECHNOLOGIES INC.	+1.22%	34.79B

Other Advanced Medical Equipment & Technology